Close Search
JDDonline - Journal of Drugs in Dermatology
  • Home
  • Issues
    • Current Issue
    • eJDD
    • Featured Articles
    • Archived Issues
    • Supplement Library
    • Case Reports
    • Unlocked Access
    • JDD Corner
    • Clinical Solutions
  • Topics
    • Atopic Dermatitis
    • Oats in Skincare
    • Oncoderm
    • Pigmentary Disorders
    • Psoriasis
    • Inclusive Dermatology Atlas
    • Social and Technology
    • Latest News
  • CME
    • CME Activities
  • Multimedia
    • JDD Corner
    • Video Abstracts
    • Podcast
    • Webinars
    • Translational Lecture Series
    • Video Pearls
  • Info
    • About JDD
    • Advertisers
      • Media Kit
      • Podcast Sponsorship
      • Reprints Contact Us
    • Authors
      • Instructions to Authors
      • Submit a Manuscript
      • Author and Peer Review Login
    • Editorial Board
    • Events
    • Contact Editorial
    • Why Publish in the JDD?
    • Institutional, Library, & Corporate Subscriptions
    • Reprints Contact Us
    • SanovaWorks
  • Inclusive Derm Atlas
    • Online Gallery
    • Digital Edition
  • Subscribe Now
  • Log In
  • x-twitter facebook linkedin instagram
Dec 10
Love0

Clinical Experience With 40% Hydrogen Peroxide Topical Solution for the Treatment of Seborrheic Keratosis

By No Comments
INTRODUCTIONAs one of the most common benign lesions, over 83 million Americans are estimated to be affected by seborrheic keratoses (SKs).1,2 The prevalence of SKs increases with age – nearly…
Read More
Dec 10
Love0

Enhancing Outcomes in Seborrheic Keratosis: Using a Novel Treatment Solution

By No Comments
INTRODUCTIONSeborrheic keratosis (SK) is one of the most common cutaneous lesions that a dermatologist will encounter daily.1 SKs can develop anywhere on the body excluding the soles, palms, and mucous…
Read More
Dec 10
Love0

Managing Seborrheic Keratoses: Real World Experience Using a Novel Treatment Solution

By No Comments
Read More
Dec 10
Love0

Clinical Pathologic Mismatch in a TNF-α Inhibitor-Associated Drug Reaction

By No Comments
INTRODUCTIONThere have been increasing reports of paradoxical inflammatory reactions induced by TNF-α inhibitors.1 Clinically, cutaneous reactions induced by TNF-α inhibitors are variable and have been described as lichenoid, psoriasiform, or…
Read More
Dec 10
Love0

Ostraceous Psoriasis Presenting as Koebner Phenomenon in a Tattoo

By No Comments
INTRODUCTIONA 21-year-old Naval active duty male presented for his first dermatologic evaluation with the chief complaint of a six-week history of mildly pruritic cutaneous lesions involving his face and recently…
Read More
Dec 10
Love0

SUPPLEMENT: Pre- and Post-Procedural Care Best Practices to Enhance Energy-Based Treatment Outcomes

By No Comments
Read More
Dec 10
Love0

ARTICLE: Pre- and Post-Procedural Care Best Practices to Enhance Energy-Based Treatment Outcomes

By No Comments
INTRODUCTIONIn recent years, numerous energy-based treatments have emerged for facial rejuvenation. Similarly, new complementary skincare options have become available to enhance the outcomes of these procedures. There are currently no…
Read More
Dec 10
Love0

FULL SUPPLEMENT: Do You Know the Most Complete, Targeted Biologic for Psoriasis? The Answer May Surprise You

By No Comments
Read More
Dec 10
Love0

ARTICLE: Think You Know IL-17 Pathway? Think Again

By No Comments
When today’s dermatology residents were born, the concept of psoriasis as a systemic disease was relatively new. Early in the 1980s, topical therapy was the mainstay for medical management of…
Read More
Dec 10
Love0

ARTICLE: IL-23 Versus IL-17 in the Pathogenesis of Psoriasis: There Is More to the Story Than IL-17A

By No Comments
INTRODUCTIONOur understanding of psoriasis pathogenesis has evolved over time. Before the 1980s, psoriasis was viewed as a skin-limited disease and the therapeutic mechanisms of commonly used treatments were not well…
Read More
Dec 10
Love0

CME: Therapeutic Insights in Melasma and Hyperpigmentation Management

By No Comments
INTRODUCTIONEPIDEMIOLOGY, CLINICAL AND HISTOLOGIC FEATURES, AND QUALITY OF LIFE Melasma Melasma is an acquired disorder of hyperpigmentation that most commonly presents as symmetrically distributed brown to gray macules and coalescent…
Read More
Dec 10
Love0

Combination Use of Systemic Therapies in Psoriasis: Baseline Characteristics from the Corrona Psoriasis Registry

By No Comments
BACKGROUNDTreatment of moderate-to-severe psoriasis often poses a challenge to the physician.1 Patients with widespread disease frequently fail to respond to initial topical treatments and phototherapy and quickly move to the…
Read More
« Previous
NextPrevious »

Search page

Advertisement

Popular

  • Tune in for the next podcast-style DermEdge episode May 12, 2026
  • Psoriatic Arthritis Awareness Month May 11, 2026
  • GLP-1 Therapies and Dermatology: A Brief Guide May 7, 2026
  • The Influence of Dermatologists’ Use of Social Media on Attracting Patients May 6, 2026
  • Podcast Refresher: Have You Listened To These Episodes? May 5, 2026

Advertisement

News Topics

  • Inclusive Derm Atlas
  • Atopic Dermatitis
  • CME
  • Featured Articles
  • Issue Highlights
  • Oats in Skincare
  • Oncoderm
  • Pigmentary Disorders
  • Psoriasis
  • Skin of Color
CONTACT US     |      FEEDBACK    |      TERMS     |      COOKIE POLICY    |     PRIVACY    |      EDITORIAL POLICY    |     ADVERTISING POLICY  |    MANAGE PREFERENCES  |  YOUR PRIVACY CHOICES

News Topics

  • Inclusive Derm Atlas
  • Atopic Dermatitis
  • CME
  • Featured Articles
  • Issue Highlights
  • Oats in Skincare
  • Oncoderm
  • Pigmentary Disorders
  • Psoriasis
  • Skin of Color
DermAtlas        Derm In-Review         PDE        Next Steps in Derm         Skin of Color Update     ODAC Dermatology, Aesthetic & Surgical Conference

Journal of Drugs in Dermatology

  • About Us
  • Contact Us
  • Contact Sales
  • Editorial Board
  • eJDD
  • Institutional, Library, & Corporate Subscriptions
  • Log In
  • Open Access
  • Permissions Request
  • Podcast Sponsorship
  • Subscription Info
  • Store

© 2026 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.

  • twitter
  • facebook
  • linkedin
  • instagram
Close Menu
  • Home
  • Issues
    • Current Issue
    • eJDD
    • Featured Articles
    • Archived Issues
    • Supplement Library
    • Case Reports
    • Unlocked Access
    • JDD Corner
    • Clinical Solutions
  • Topics
    • Atopic Dermatitis
    • Oats in Skincare
    • Oncoderm
    • Pigmentary Disorders
    • Psoriasis
    • Inclusive Dermatology Atlas
    • Social and Technology
    • Latest News
  • CME
    • CME Activities
  • Multimedia
    • JDD Corner
    • Video Abstracts
    • Podcast
    • Webinars
    • Translational Lecture Series
    • Video Pearls
  • Info
    • About JDD
    • Advertisers
      • Media Kit
      • Podcast Sponsorship
      • Reprints Contact Us
    • Authors
      • Instructions to Authors
      • Submit a Manuscript
      • Author and Peer Review Login
    • Editorial Board
    • Events
    • Contact Editorial
    • Why Publish in the JDD?
    • Institutional, Library, & Corporate Subscriptions
    • Reprints Contact Us
    • SanovaWorks
  • Inclusive Derm Atlas
    • Online Gallery
    • Digital Edition
  • Subscribe Now
  • Log In

Search

  • x-twitter
  • facebook
  • linkedin
  • instagram